Signature Resources Capital Management’s AbbVie ABBV Stock Holding History

Signature Resources Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Buy	838 +130	+18%	+$28K	0.08%	72
2026 Q1	$154K	Buy	708 +107	+18%	+$23.7K	0.07%	73
2025 Q4	$137K	Sell	601 -63	-9%	-$14.4K	0.07%	81
2025 Q3	$154K	Sell	664 -79	-11%	-$16.1K	0.08%	72
2025 Q2	$138K	Buy	743 +4	+0.5%	+$743	0.08%	71
2025 Q1	$155K	Hold	739	–	–	0.13%	56
2024 Q4	$131K	Hold	739	–	–	0.12%	55
2024 Q3	$146K	Sell	739 -354	-32%	-$66.1K	0.13%	51
2024 Q2	$187K	Sell	1,093 -115	-10%	-$19.1K	0.16%	49
2024 Q1	$187K	Hold	1,208	–	–	0.18%	45
2023 Q4	$187K	Buy	+1,208	New	+$176K	0.17%	45

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Signature Resources Capital Management's ABBV Position: Q2 2026 in Review

Signature Resources Capital Management increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $28K and bringing the position to 838 shares worth $211K. The position accounts for 0.08% of the portfolio, ranked #72.

Signature Resources Capital Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Signature Resources Capital Management held 838 shares of AbbVie worth $211K as of Q2 2026.
Signature Resources Capital Management bought 130 AbbVie shares in Q2 2026, an estimated $28K.
AbbVie made up 0.08% of Signature Resources Capital Management's portfolio in Q2 2026, its #72 holding.
Signature Resources Capital Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.